Filter results
Type
Audience
Last updated
Topics
-
A guide for registry-based trials – National Clinical Quality Registry Program
Resources › Publications12 June 2025 - This guide provides information for Clinical Quality Registry operators and researchers on how to conduct registry-based trials. This guide also offers practical tools and examples to support implementation.
-
ATAGI recommendations on COVID-19 vaccine use in children aged 6 months to <5 years
News and media8 April 2025 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) COVID-19 vaccine use in children.
-
Pharmacy Trial Program
Our work21 September 2023 - The Pharmacy Trial Program aims to trial new services that expand the role of pharmacists delivering primary health care and improve clinical outcomes for consumers. At the end of the trials, a health technology assessment will inform decisions on future funding.
-
Medical devices
Topics12 November 2025 - Medical devices can be used to diagnose, prevent, treat and monitor medical conditions. They include things like surgical equipment, syringes, gloves, pacemakers, baby incubators and implants. Find out what we’re doing to make sure these products are safe to use.
-
Natural Therapies Review Expert Advisory Panel
Committees and groups16 March 2025 - The Natural Therapies Review Expert Advisory Panel (NTREAP) supported the Natural Therapies Review 2024. The final meeting was held on 10 December 2024.
-
ATAGI statement on use of the Moderna bivalent Original/Omicron vaccine
News and media8 April 2025 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 Moderna Spikevax Bivalent Original/Omicron BA.1 vaccine.
-
National Clinical Quality Registry Program – Best practice materials
Resources › Collections6 November 2025 - This collection contains a suite of best practice guides developed under the National Clinical Quality Registry Program.
-
Vaccine safety
Topics › Immunisation › About immunisation7 August 2023 - Find out how vaccines are developed, tested and monitored for safety in Australia.
-
All MRFF initiatives
Our work › Medical Research Future Fund26 July 2024 - The Medical Research Future Fund (MRFF) supports a range of research initiatives to improve the health of Australians. Discover the details of the initiatives we’re funding.
-
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine
News and media9 June 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine.